Tag: RSV
Astra-Sanofi’s RSV treatment “very effective” against infant hospitalizations, CDC study finds – 03/07/2024 at 9:00 p.m.
((Automated translation by Reuters, please see disclaimer https://bit.ly/rtrsauto)) (Correction of a typo in the name of the CDC agency in paragraph 1) AstraZeneca’s antibody therapy AZN.L and Sanofi SASY.PA were…
Astra-Sanofi’s RSV treatment is 90% effective against infant hospitalizations, CDC study finds – 03/07/2024 at 9:22 p.m.
((Automated translation by Reuters, please see disclaimer https://bit.ly/rtrsauto)) (Adds details of the report in paragraphs 4,6,7, as well as general information) AstraZeneca’s antibody treatment AZN.L and Sanofi SASY.PA were 90%…
Moderna: Surprise Q4 profit, details RSV vaccine roadmap
Published on 02/22/2024 at 1:56 p.m. Feb 22 (Reuters) – Moderna reported a surprise fourth-quarter profit on Thursday, driven by lower costs and…
AstraZeneca and Sanofi to supply 230,000 additional RSV vaccines for infants to the US market – 12/14/2023 at 10:38 p.m.
(Adds details from Sanofi in paragraphs 2, 9 and 10) by Trevor Hunnicutt and Michael Erman Makers of a respiratory syncytial virus (RSV) vaccine for infants, whose supply is limited,…
CDC accelerates availability of 77,000 additional doses of Sanofi-AstraZeneca RSV drug – 11/17/2023 at 02:39
(Corrects title and first paragraph to reflect that CDC accelerated the release of doses, not released doses) The U.S. Centers for Disease Control and Prevention (CDC) announced Thursday that it…
CDC accelerates availability of 77,000 additional doses of Sanofi-AstraZeneca RSV drug – 11/17/2023 at 02:39
(Corrects title and first paragraph to reflect that CDC accelerated the release of doses, not released doses) The US Centers for Disease Control and Prevention (CDC) announced on Thursday that…
AstraZeneca prioritizes US for its RSV drug due to rising cases – 11/10/2023 at 8:18 p.m.
by Patrick Wingrove and Maggie Fick AstraZeneca AZN.L said on Friday it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was…
Market: GSK sues Pfizer in the United States for patent infringement concerning the RSV vaccine
(Reuters) – The British laboratory GSK on Wednesday filed a complaint against Pfizer in a Delaware court in the United States for patent infringement. The pharmaceutical group accuses its American…
Moderna: deposits for RSV vaccine candidate
(CercleFinance.com) – Moderna today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and diseases respiratory tract infections (ARD)…
AstraZeneca: FDA recommends nirsevimab for RSV
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Influenza and RSV: Small children in particular are affected by the wave of illness
Flu and RSV Small children in particular are affected by the wave of diseases © Viacheslav Yakobchuk / Adobe Stock News in December that moves us: Flu epidemic already above…
Pfizer: requests license for RSV vaccine
(CercleFinance.com) – Pfizer today announced that the U.S. Food and Drug Administration (FDA) has agreed to prioritize a Biological License Application (BLA) for its respiratory syncytial virus vaccine candidate (…